Optum Epidemiology
Boston, Massachusetts, United States
Dr. Seeger joined Optum in 2001. In addition to this role, Dr. Seeger is adjunct faculty at Harvard T.H. Chan School of Public Health. Dr. Seeger received a PharmD from the University of Arizona, an MPH from the University of Michigan and a DrPH from Harvard School of Public Health. Trained as a clinical pharmacist, Dr. Seeger spent three years on the faculty of the University of Illinois at Chicago, where he also completed a residency in pharmacy practice. He also spent five years on faculty at Harvard Medical School, Division of Pharmacoepidemiology. Dr. Seeger’s research interests are predictors of drug therapy and the application of research methods that incorporate these predictors. He has worked extensively with propensity scores and related methods that seek to mitigate confounding by modeling drug therapy. He has applied these methods to research involving a wide range of therapeutic areas, including diabetes and rheumatologic, cardiovascular, neurologic and gastrointestinal disorders, as well as in vaccine safety and drug effects in pregnancy. Most of this work has involved the application of health insurance claims data as a foundation for studies of post-marketing drug safety. However, the availability of new data resources (particularly electronic health records) has expanded the range of questions that can be addressed through observational techniques and correspondingly expanded the scope of Dr. Seeger’s work. He has authored or co-authored more than 100 articles in peer-reviewed medical literature and is a long-term member, past President, and Fellow of the International Society for Pharmacoepidemiology.
Astellas (Other Research Support includes receipt of drugs, supplies, equipment or other in-kind support, The work was funded with a research contract between Optum and Astellas.)Intercept Pharmaceuticals, Inc. (Contracted Research)Optum (Employment)UnitedHealth Group (Ownership Interest includes stock, stock options, patent or other intellectual property)
Monday, August 23, 2021
11:45 AM – 1:30 PM US Eastern Time
OP-18E - Validity of ICD-10 Z3A Codes for Estimating Date of Last Menstrual Period
Monday, August 23, 2021
1:45 PM – 3:30 PM US Eastern Time
Tuesday, August 24, 2021
11:45 AM – 1:15 PM US Eastern Time
OP-23D - Anticoagulants and All-cause Mortality Among Hospitalized COVID-19 Patients
Tuesday, August 24, 2021
1:45 PM – 3:30 PM US Eastern Time
Tuesday, August 24, 2021
1:45 PM – 3:30 PM US Eastern Time
Tuesday, August 24, 2021
5:15 PM – 6:30 PM US Eastern Time
SP17C - New-onset Autoimmune Disease (AID) Detection and Validation in Healthcare Databases
Tuesday, August 24, 2021
5:15 PM – 6:30 PM US Eastern Time
Wednesday, August 25, 2021
11:45 AM – 1:30 PM US Eastern Time
Wednesday, August 25, 2021
11:45 AM – 1:30 PM US Eastern Time
Wednesday, August 25, 2021
4:30 PM – 6:00 PM US Eastern Time